All theories also emphasize a basic abnormality in the immune surveillance system, which in some way allows autoimmunity to develop against thyroid antigens, and as well against other tissues, including stomach, adrenal, and ovaries, in many patients with thyroiditis
Confirmed by FDA NDA 215866 tirzepatide Clinical Pharmacology Review showing Japanese lean cohort amplified HR sensitivity at matched exposure
Highmark releases March 2023 Plan for Health Newsletter: March 2023 Plan for Health Newsletter Focus on Mental Health crisis lines included with self-care & coping skills March Wellness Poster March Recipe Flyer February 2023 Updates: Corrected Highmark WPA Brochures Digital Files: Updated WPA Small Group Sold Checklists: SMALL GROUP SOLD GROUP CHECKLIST CPA SMALL GROUP SOLD GROUP CHECKLIST NEPA SMALL GROUP SOLD GROUP CHECKLIST WPA SMALL GROUP SOLD GROUP CHECKLIST WV Highmark Spring 2023 Broker Webinar Training Series: February 28 @ 10 AM: High Performing Networks March 1 @ 9 AM: Mental Health Parity 10 AM: Pharmacy Updates 2 PM: Large Group New Business Quote Requirements March 2 @ 10 AM: Analytics Navigator March 8 @ 2 PM: PA Blue Edge Dental Updates March 9 @ 10:30 AM: My Highmark Mobile App & Website 3:30 PM: NY Blue Edge Dental Updates March 13 @ 1:30 PM: WV Blue Edge Dental Updates March 14 @ 10 AM: Social Determinants of Health (SDoH) 2 PM: Large Group New Business Implementation Onboarding Portal 3 PM: DE Blue Edge Dental Updates March 15 @ 2 PM: Medical Underwriting & FormFire March 22 @ 10 AM: Well360 Motion powered by SWORD 3 PM: NY Product Review & Clinical Management Solutions March 23 @ 10:30 AM: Medically Tailored Meals (Food 2.0) January 2023 Updates: Highmark released a Mental Health Parity (MHP) 2023 Compliance Update: Effects business in DE, PA & WV Impacts urgent care, out-patient diagnostic services & therapy services (physical medicine, occupational therapy, speech therapy) Updates are effective upon renewal January 1, 2023 forward, for all fully-insured clients Highmark released their February 2023 Plan for Health Newsletter
The latest GLP-1 agonist medication, tirzepatide (trade name Mounjaro), seems to be the most effective GLP-1 agonist for weight loss yet, resulting in substantial and sustained reductions in body weight in a 2022 trial
